BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 15090718)

  • 21. International trends in prostate-cancer mortality in the "PSA ERA".
    Oliver SE; May MT; Gunnell D
    Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent trends in prostate cancer mortality show a continuous decrease in several countries.
    Bouchardy C; Fioretta G; Rapiti E; Verkooijen HM; Rapin CH; Schmidlin F; Miralbell R; Zanetti R
    Int J Cancer; 2008 Jul; 123(2):421-429. PubMed ID: 18452171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
    Brenner H; Arndt V
    J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International trends in prostate-cancer mortality: the decrease is continuing and spreading.
    Baade PD; Coory MD; Aitken JF
    Cancer Causes Control; 2004 Apr; 15(3):237-41. PubMed ID: 15090718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.
    Quinn M; Babb P
    BJU Int; 2002 Jul; 90(2):162-73. PubMed ID: 12081758
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.